G. Rodgers

A. Schechter, M. Roy, C. Noguchi, 1987, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

Noninvasive techniques to evaluate the vaso-occlusive manifestations of sickle cell disease.

A. Schechter, C. Noguchi, G. Rodgers, 1985, The American journal of pediatric hematology/oncology.

Hydroxyurea therapy in β‐thalassaemia intermedia: improvement in haematological parameters due to enhanced β‐globin synthesis

A. Schechter, Z. Ren, G. Rodgers, 1995 .

Hemolytic anemia-associated pulmonary hypertension in sickle cell disease.

Elaina E. Lin, M. Gladwin, G. Rodgers, 2005, Current hematology reports.

Olfm4 deletion enhances defense against Staphylococcus aureus in chronic granulomatous disease.

Wenli Liu, K. Kwon-Chung, G. Rodgers, 2013, The Journal of clinical investigation.

Olfm 4 deletion enhances defense against Staphylococcus aureus in chronic granulomatous disease

Ming Yan, Wenli Liu, G. Rodgers, 2013 .

Glia Maturation Factor-Gamma Regulates Autophagy and Scavenger Receptor-Mediated Phagocytosis in Murine Macrophages

K. Chin, Jianqiong Zhu, G. Rodgers, 2021 .

Precision Nutrition-the Answer to "What to Eat to Stay Healthy".

F. Collins, G. Rodgers, 2020, JAMA.

Pathogenesis and treatment of acute chest syndrome of sickle-cell anaemia

M. Gladwin, G. Rodgers, 2000, The Lancet.

Glycemic Therapy for Type 2 Diabetes: Choices Expand, Data Lag Behind

J. Fradkin, G. Rodgers, 2017, Annals of Internal Medicine.

Hydroxyurea-inducible SAR1 gene acts through the Giα/JNK/Jun pathway to regulate γ-globin expression.

K. Chin, Jianqiong Zhu, G. Rodgers, 2014, Blood.

RED CELLS , IRON , AND ERYTHROPOIESIS Hydroxyurea-inducible SAR 1 gene acts through the Gi a / JNK / Jun pathway to regulate g-globin expression

K. Chin, Jianqiong Zhu, G. Rodgers, 2014 .

Hydroxyurea-Increased Fetal Hemoglobin Is Associated with Less Organ Damage and Longer Survival in Adults with Sickle Cell Anemia

A. Schechter, J. Tisdale, G. Rodgers, 2015, PloS one.

Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection

Yueqin Liu, Wenli Liu, Cuiling Li, 2010, Proceedings of the National Academy of Sciences.

In vivo and in vitro studies of fetal hemoglobin induction by hydroxyurea in beta-thalassemia/hemoglobin E patients.

S. Fucharoen, G. Rodgers, S. Chuncharunee, 2005, Experimental hematology.

Sequence of the —530 region of the β‐globin gene of sickle cell anemia patients with the Arabian haplotype

A. Schechter, S. Huang, S. Perrine, 1994, Human mutation.

Intracellular Polymerization

A. Schechter, C. Noguchi, G. Rodgers, 1989, Annals of the New York Academy of Sciences.

Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.

J. Powell, J. Tisdale, G. Rodgers, 2014, JAMA.

Filterability of mixtures of sickle and normal erythrocytes

A. Schechter, C. Noguchi, G. Rodgers, 1995, American journal of hematology.

cell disease A case for developing North-South partnerships for research in sickle

K. Hofman, D. Weatherall, Sharon H. Hrynkow, 2013 .

A case for developing North-South partnerships for research in sickle cell disease.

K. Hofman, D. Weatherall, Sharon H. Hrynkow, 2005, Blood.

The Delta-Globin RNA Transcript Level in Beta-Thalassemia Carriers

A. Schechter, Mei-jue Chen, Z. Ren, 1999, Acta Haematologica.

The e w e n g a d j o u r n a l of m e d i c i n e Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease

J. Powell, J. Tisdale, R. Childs, 2009 .

Polymorphisms within the angiotensinogen gene (GT‐Repeat) and the risk of stroke in pediatric patients with sickle cell disease: A case‐control study

R. Hirsch, Kye-Hyun Kim, Wenli Liu, 2001, American journal of hematology.

Red Blood Cell Glucose‐6‐phosphate Dehydrogenase Activity in Aged Humans

G. Rodgers, M. Sheff, H. Lichtman, 1983, Journal of the American Geriatrics Society.

Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2'-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis.

Yueqin Liu, Wenli Liu, G. Rodgers, 2010, Blood.

in Escherichia coli and Staphylococcus aureus Modulating Neutrophil Killing of C-Mediated Protease Activities, Thereby Olfactomedin 4 Inhibits Cathepsin

Yueqin Liu, K. Mcleish, G. Rodgers, 2012 .

RNA transcripts of the β‐thalassaemia allele IVS‐2–654 C → T: a small amount of normally processed β‐globin mRNA is still produced from the mutant gene

A. Schechter, Z. Ren, G. Rodgers, 1994 .

Comparison of CD34+ cells isolated from frozen cord blood and fresh adult peripheral blood of sickle cell disease patients in gene correction of the sickle mutation at late‐stage erythroid differentiation

J. Tisdale, G. Rodgers, C. Kumkhaek, 2021, British journal of haematology.

Pulse oximeter measurements of oxygen saturation in sickle cell blood

A. Schechter, C. Noguchi, G. Rodgers, 1988, Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

Monoclonal antibody‐based methods for quantitation of hemoglobins: application to evaluating patients with sickle cell anemia treated with hydroxyurea

E. Fibach, G. Rodgers, M. Epstein, 1996, European journal of haematology.

Pathogenesis of Lung Disease in Sickle Hemoglobinopathies

J. Weil, A. Malik, O. Castro, 1993 .

Olfactomedin 4 Is a Biomarker for the Severity of Infectious Diseases.

Wenli Liu, G. Rodgers, 2022, Open forum infectious diseases.

The glycoprotein hGC-1 binds to cadherin and lectins.

Wenli Liu, G. Rodgers, J. Zhu, 2006, Experimental cell research.

Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.

A. Schechter, S. Antonarakis, D. Weatherall, 1985, The Journal of clinical investigation.

Prospective identification of erythroid elements in cultured peripheral blood.

J. Miller, A. Gubin, J. Njoroge, 1999, Experimental hematology.

Single nucleotide polymorphisms in SAR1A coding regions in sickle cell disease and their potential miRNA binding sites

Jianqiong Zhu, G. Rodgers, Christine Kim, 2022, EJHaem.

Research on Childhood Obesity: Building the Foundation for a Healthier Future.

G. Rodgers, William Dietz, R. Lavizzo-Mourey, 2018, American journal of preventive medicine.

Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer

Wenli Liu, G. Rodgers, 2016, Cancer and Metastasis Reviews.

Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.

G. Rodgers, 1992, Seminars in oncology.

Restoration of the CCAAT Box or Insertion of the CACCC Motif Activate δ-Globin Gene Expression

R. Hardison, D. Tang, G. Rodgers, 1997 .

Acquired sideroblastic anaemia following progesterone therapy

N. Young, R. Brodsky, E. Fibach, 1994, British journal of haematology.

SCF induces gamma-globin gene expression by regulating downstream transcription factor COUP-TFII.

K. Chin, Jianqiong Zhu, G. Rodgers, 2009, Blood.

Analyses of genome wide association data, cytokines, and gene expression in African-Americans with benign ethnic neutropenia

Mary Cushman, Leslie A McClure, Griffin P Rodgers, 2018, PloS one.

Urinary Stone Disease: Progress, Status, and Needs.

R. Rasooly, R. Star, Z. Kırkalı, 2015, Urology.

Hydroxyurea therapy in beta-thalassaemia intermedia: improvement in haematological parameters due to enhanced beta-globin synthesis.

A. Schechter, Z. Ren, S. Huang, 1995, British journal of haematology.

Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea.

A. Schechter, A. Nienhuis, C. Noguchi, 1990, The New England journal of medicine.

Treatment of beta-thalassemia with hydroxyurea (HU)--effects of HU on globin gene expression.

A. Schechter, Z. Ren, S. Huang, 1994, Science in China. Series B, Chemistry, life sciences & earth sciences.

Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity.

M. Gladwin, F. Ognibene, L. Pannell, 1999, The Journal of clinical investigation.

Cryoprecipitate therapy in amniotic fluid embolization.

G. Rodgers, G. J. Heymach, 1984, The American journal of medicine.

Gene Expression (1086 articles)

K. Chin, Jianqiong Zhu, G. Rodgers, 2006 .

Mortality in sickle cell disease.

G. Rodgers, M. Podgor, E. Walker, 1994 .

Discovery of phenylsulfonylfuroxan derivatives as gamma globin inducers by histone acetylation.

R. Fruttero, F. Costa, G. Rodgers, 2018, European journal of medicinal chemistry.

Fetal haemoglobin response to hydroxycarbamide treatment and sar1a promoter polymorphisms in sickle cell anaemia

G. Kato, Jianqiong Zhu, G. Rodgers, 2008, British journal of haematology.

Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.

A. Schechter, A. Nienhuis, C. Noguchi, 1993, The New England journal of medicine.

Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease

M. Gladwin, F. Ognibene, L. Pannell, 2002, British journal of haematology.

The hydroxyurea-induced small GTP-binding protein SAR modulates gamma-globin gene expression in human erythroid cells.

J. Hanover, Wenli Liu, D. Tang, 2005, Blood.

3 Sickle cell disease pathophysiology

A. Schechter, C. Noguchi, G. Rodgers, 1993 .

Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease.

S. Chanock, S. Savage, D. Tang, 2002, Blood.

Two‐phase liquid culture system models normal human adult erythropoiesis at the molecular level

K. Chin, E. Fibach, G. Rodgers, 2000, European journal of haematology.

NOVEL TREATMENT OPTIONS IN THE SEVERE β‐GLOBIN DISORDERS

G. Rodgers, E. Rachmilewitz, 1995, British journal of haematology.

CLINICAL AND HEMATOLOGICAL RESPONSES TO HYDROXYUREA IN SICILIAN PATIENTS WITH Hb S/β-THALASSEMIA

G. Rodgers, A. Maggio, D. Renda, 2001 .

Sickle cell disease pathophysiology.

A. Schechter, C. Noguchi, G. Rodgers, 1993, Bailliere's clinical haematology.

Sickle cell anemia--basic research reaches the clinic.

A. Schechter, G. Rodgers, 1995, The New England journal of medicine.

Irreversibly sickled erythrocytes in sickle cell anemia: A quantitative reappraisal

A. Schechter, C. Noguchi, G. Rodgers, 1985, American journal of hematology.

Advances in experimental treatment of beta-thalassaemia.

Y. Saunthararajah, G. Rodgers, 2001, Expert opinion on investigational drugs.

Pathophysiology of sickle cell disease: role of cellular and genetic modifiers.

M. Steinberg, G. Rodgers, M H Steinberg, 2001, Seminars in hematology.

Sickle Cell Anemia Therapy: Progress Since Pauling

A. Schechter, G. Rodgers, 2000, Science.

cell disease gene and risk for symptomatic stroke in sickle VCAM1 Variants in the

S. Chanock, S. Savage, D. Tang, 2011 .

Periodic microcirculatory flow in patients with sickle-cell disease.

A. Schechter, R. Bonner, A. Nienhuis, 1984, The New England journal of medicine.

Intracellular polymerization of sickle hemoglobin: disease severity and therapeutic goals.

A. Schechter, C. Noguchi, G. Rodgers, 1987, Progress in clinical and biological research.

Microcirculatory adaptations in sickle cell anemia: reactive hyperemia response.

A. Schechter, R. Bonner, A. Nienhuis, 1986, The American journal of physiology.

Conjunctival sign in sickle cell anaemia: an in-vivo correlate of the extent of red cell heterogeneity.

A. Schechter, A. Nienhuis, M. Roy, 1985, The British journal of ophthalmology.

HbA2: biology, clinical relevance and a possible target for ameliorating sickle cell disease

M. Steinberg, G. Rodgers, 2015, British journal of haematology.

RNA transcripts of the beta-thalassaemia allele IVS-2-654 C-->T: a small amount of normally processed beta-globin mRNA is still produced from the mutant gene.

A. Schechter, Z. Ren, S. Huang, 1994, British journal of haematology.

Diagnosis of thalassemia using cDNA amplification of circulating erythroid cell mRNA with the polymerase chain reaction.

A. Schechter, S. Huang, Y. Zeng, 1992, Blood.

Diagnosis of thalassemia using cDNA amplification of circulating erythroid cell mRNA with the polymerase chain reaction.

A. Schechter, S. Huang, Y. Zeng, 1991, Blood.

HB Q-Thailand [α74(EF3)ASP→HIS] : gene organization, molecular structure, and DNA diagnosis

S. Fucharoen, S. Huang, G. Rodgers, 1992 .

Hb seal rock [(α2)142 term→Glow, Codon 142 TAA→GAA]: An extended α chain variant associated with Anemia, Microcytosis, and α-Thalassemia-2 (- 3.7 Kb)a

S. Thibodeau, M. Steinberg, G. Rodgers, 1997 .

Sickle Cell Disease: Demystifying the Beginnings

G. Rodgers, C. Reid, 2007 .

Olfactomedin 4 deficiency promotes prostate neoplastic progression and is associated with upregulation of the hedgehog-signaling pathway

C. Deng, Wenli Liu, WeiPing Chen, 2015, Scientific Reports.

Olfactomedin 4 mediation of prostate stem/progenitor-like cell proliferation and differentiation via MYC

M. Pirooznia, Wenli Liu, K. Chin, 2020, Scientific Reports.

Olfactomedin 4 suppresses prostate cancer cell growth and metastasis via negative interaction with cathepsin D and SDF-1.

Liu Cao, Wenli Liu, Jianqiong Zhu, 2011, Carcinogenesis.

Identification and characterization of a novel member of olfactomedin-related protein family, hGC-1, expressed during myeloid lineage development.

Min Wang, D. Tang, G. Rodgers, 2002, Gene.

Inhibition of β protein 1 expression enhances β-globin promoter activity and β-globin mRNA levels in the human erythroleukemia (K562) cell line

G. Rodgers, O. Zoueva, 2004 .

von Hippel-Lindau Disease-Associated Hemangioblastomas Are Derived from Embryologic Multipotent Cells

Deric M. Park, A. Vortmeyer, I. Lubensky, 2007, PLoS medicine.

Benign Ethnic Neutropenia in Individuals of African Descent: Incidence, Granulocyte Mobilization, and Gene Expression Profiling.

J. Everhart, E. Wang, Kayu Chin, 2005 .

Enrichment and detection of fetal erythroid cells from maternal peripheral blood using liquid culture

Joo-In Park, G. Rodgers, Jin-Yeong Han, 2001, Prenatal diagnosis.

Radil controls neutrophil adhesion and motility through β2-integrin activation

C. Parent, S. Angers, Lunhua Liu, 2012, Molecular biology of the cell.

Allogeneic hematopoietic stem-cell transplantation for sickle cell disease.

Jonathan D. Powell, Griffin P. Rodgers, J. Powell, 2009, The New England journal of medicine.

NHLBI Workshop Summary. Pathogenesis of lung disease in sickle hemoglobinopathies.

J. Weil, A. Malik, O. Castro, 1993, The American review of respiratory disease.

Mobilization, collection, and processing of peripheral blood stem cells in individuals with sickle cell trait.

J. Tisdale, G. Rodgers, E. Read, 2002, Blood.

MASL1 induces erythroid differentiation in human erythropoietin-dependent CD34+ cells through the Raf/MEK/ERK pathway.

Wenli Liu, J. Tisdale, Jianqiong Zhu, 2013, Blood.

Culture of fetal erythroid cells from maternal blood using a two-phase liquid system.

G. Rodgers, G. Je, J. Y. Han, 1999, American journal of medical genetics.

Social Determinants of Racial Disparities in CKD.

Jenna M. Norton, P. Kimmel, P. Eggers, 2016, Journal of the American Society of Nephrology : JASN.

Influence of lineage‐specific cytokines on commitment and asymmetric cell division of haematopoietic progenitor cells

Griffin P Rodgers, D. Tang, E. Fibach, 2002, British journal of haematology.

Evaluation of Rhesus Rotavirus Monovalent and Tetravalent Reassortant Vaccines in US Children

R. Glass, M. Pichichero, M. Rennels, 1995 .

Glia Maturation Factor-γ Negatively Modulates TLR4 Signaling by Facilitating TLR4 Endocytic Trafficking in Macrophages

K. Chin, G. Rodgers, W. Aerbajinai, 2013, The Journal of Immunology.

Evolutionary context for the association of γ-globin, serum uric acid, and hypertension in African Americans

C. Rotimi, A. Adeyemo, D. Shriner, 2015, BMC Medical Genetics.

Inhibition of beta protein 1 expression enhances beta-globin promoter activity and beta-globin mRNA levels in the human erythroleukemia (K562) cell line.

G. Rodgers, O. Zoueva, 2004, Experimental Hematology.

Recent advances in use of fresh frozen plasma, cryoprecipitate, immunoglobulins, and clotting factors for transfusion support in patients with hematologic disease

M. A. Meledeo, M. Steinberg, G. Rodgers, 2020, Seminars in Hematology.

Sickling of nucleated erythroid precursors from patients with sickle cell anemia.

A. Schechter, C. Noguchi, E. Fibach, 1998, Experimental hematology.

Role of MFHAS1 in regulating hepcidin expression via the BMP/SMAD and MAPK/ERK1/2 signalling pathways

Jianqiong Zhu, G. Rodgers, W. Aerbajinai, 2019, British journal of haematology.

Recombinant erythroid Kruppel-like factor fused to GATA1 up-regulates delta- and gamma-globin expression in erythroid cells.

C. Trainor, K. Chin, Jianqiong Zhu, 2010, Blood.

Recombinant erythroid Kruppel-like factor fused to GATA 1 upregulates globin expression in erythroid cells

C. Trainor, K. Chin, Jianqiong Zhu, 2011 .

BP1 motif in the human beta-globin promoter affects beta-globin expression during embryonic/fetal erythropoiesis in transgenic mice bearing the human beta-globin gene.

D. Bodine, G. Rodgers, L. Garrett, 2008, Blood cells, molecules & diseases.

Identification of upstream regulatory elements that repress expression of adult beta-like globin genes in a primitive erythroid environment.

D. Tang, K. Chin, G. Rodgers, 1998, Blood cells, molecules & diseases.

In vivo footprinting using N-ethyl,N-nitrosourea: improved resolution of the DNA-protein interactions in the human gamma-globin gene promoter region.

G. Rodgers, I. H. Kim, I. Kim, 1997, Analytical biochemistry.

Deletion of the olfactomedin 4 gene is associated with progression of human prostate cancer.

M. Emmert-Buck, J. Rodriguez-Canales, Wenli Liu, 2013, The American journal of pathology.

Glia Maturation Factor Gamma (GMFG): A Cytokine-Responsive Protein During Hematopoietic Lineage Development and Its Functional Genomics Analysis

Ling Chen, Ying Shi, Lance A. Liotta, 2006, Genom. Proteom. Bioinform..

Celebrating 30 Years of Research Accomplishments of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study

C. Cowie, J. Fradkin, G. Rodgers, 2013, Diabetes.

The regulation of OLFM4 expression in myeloid precursor cells relies on NF‐κB transcription factor

Wenli Liu, K. Chin, G. Rodgers, 2008, British journal of haematology.

Biomedical research: paving a pathway to diabetes prevention.

J. Wallace, J. Fradkin, G. Rodgers, 2013, American journal of preventive medicine.

Type 1 Diabetes—Reaping the Rewards of a Targeted Research Investment

B. Akolkar, J. Wallace, J. Fradkin, 2016, Diabetes.

The Economic Imperative to Conquer Diabetes The views expressed in this article are those of the authors and do not represent the position of the U.S. Government.

J. Fradkin, G. Rodgers, 2008, Diabetes Care.

What's preventing us from preventing type 2 diabetes?

J. Fradkin, B. T. Roberts, G. Rodgers, 2012, The New England journal of medicine.

Hemoglobin SC disease and alpha-thalassemia. Prolonged survival and mild clinical course.

A. Schechter, N. Anagnou, C. Noguchi, 1986, The American journal of medicine.

Brain glucose metabolism in neurologically normal patients with sickle cell disease. Regional alterations.

A. Schechter, S. Larson, C. Clark, 1988, Archives of neurology.

Rapid differentiation of five common α-thalassemia genotypes by polymerase chain reaction☆

S. Fucharoen, D. Tang, G. Rodgers, 2001 .

COVID-19 and metabolic diseases: a heightened awareness of health inequities and a renewed focus for research priorities

W. Cefalu, G. Rodgers, 2021, Cell Metabolism.

Nitric oxide transport on sickle cell hemoglobin: Where does it bind?

M. Gladwin, F. Ognibene, M. Pease-Fye, 2001, Free radical research.

Basic science: Bedrock of progress.

Christopher P Austin, Andrea Norris, William T Riley, 2016, Science.

Advancing a Comprehensive Approach to the Study of Lower Urinary Tract Symptoms.

Jenna M. Norton, J. Kusek, R. Star, 2016, The Journal of urology.

Glimmers in illuminating the druggable genome

Christine Colvis, Christopher Austin, Aaron Pawlyk, 2018, Nature Reviews Drug Discovery.

Achieving Health Equity Through Digestive Diseases Research and Scientific Workforce Diversity

G. Germino, G. Rodgers, S. P. James, 2022, Gastroenterology.

NIDDK initiatives addressing health disparities in chronic diseases.

B. T. Roberts, G. Rodgers, 2020, The Journal of clinical investigation.

Bethesda Handbook of Clinical Hematology

Griffin P. Rodgers, N. Young, G. Rodgers, 2008 .

Impaired deformability of Heinz body-forming red cells.

A. Schechter, G. Rodgers, H. Shio, 1993, Biorheology.

Use of selective vasodilation in treatment of sickle cell disease.

A. Schechter, M. Roy, C. Noguchi, 1988, The American journal of pediatric hematology/oncology.

NIDDK Programs and Emerging Opportunities for Digestive Diseases Research.

S. James, G. Rodgers, Michael J. Grey, 2015, Gastroenterology.

Effect of nitric oxide and nitric oxide donors on red blood cell oxygen transport

M. Gladwin, A. Schechter, D. Wink, 2000, British journal of haematology.

Unusual case of iron intoxication.

G. Rodgers, D. E. Kolins, D. Finger, 1987, Journal of toxicology. Clinical toxicology.

The next generation of obesity research: no time to waste.

Francis S Collins, Griffin P Rodgers, F. Collins, 2012, JAMA.

Abstract 2695: Olfactomedin 4 gene is associated with progression of prostate cancer: Evidence from an OLFM4 knockout mouse model

M. Emmert-Buck, C. Deng, J. Rodriguez-Canales, 2012 .

Olfactomedin 4 Is Essential for Superoxide Production and Sensitizes Oxidative Stress-Induced Apoptosis in Neutrophils.

C. Deng, Yueqin Liu, Wenli Liu, 2009 .

Hb Seal Rock [(alpha 2)142 term-->Glu, codon 142 TAA-->GAA]: an extended alpha chain variant associated with anemia, microcytosis, and alpha-thalassemia-2 (-3.7 Kb).

S. Thibodeau, M. Steinberg, G. Rodgers, 1997, Hemoglobin.

Variation in the Small Guanosine Triphosphate (GTP)-Binding Protein, Secretion-Associated and RAS-Related (SAR1A) Gene and Response to Hydroxyurea Treatment in Sickle Cell Disease.

G. Kato, Jianqiong Zhu, G. Rodgers, 2007 .

Overview of pathophysiology and rationale for treatment of sickle cell anemia.

G. Rodgers, 1997, Seminars in hematology.

Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease.

A. Schechter, S. Fucharoen, N. Poolsup, 1996, Blood.

Identification and characterization of novel full-length cDNAs expressed during hematopoietic lineage-specific differentiation of cultured human peripheral blood mononuclear cells.

Wenli Liu, G. Rodgers, C. Kumkhaek, 2013, Blood cells, molecules & diseases.

Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer

J. Rodriguez-Canales, Wenli Liu, Jianqiong Zhu, 2019, International journal of cancer.

Diabetes Research: A Perspective From the National Institute of Diabetes and Digestive and Kidney Diseases

J. Fradkin, G. Rodgers, 2013, Diabetes.

Deoxyhemoglobin S polymer formation in sickle cells.

A. Schechter, C. Noguchi, G. Rodgers, 1986, Blood.

Induction of fetal hemoglobin in sickle cell patients by hydroxyurea: the N.I.H. experience.

A. Schechter, A. Nienhuis, C. Noguchi, 1989, Progress in clinical and biological research.

The TODAY Study: An NIH Perspective on Its Implications for Research

B. Linder, J. Fradkin, G. Rodgers, 2013, Diabetes Care.

Glia Maturation Factor-γ Regulates Autophagy in Murine Macrophages

K. Chin, Jianqiong Zhu, G. Rodgers, 2019, Blood.

Mortality in sickle cell disease.

G. Rodgers, M. Podgor, E. Walker, 1994, The New England journal of medicine.

Olfactomedin 4 contributes to hydrogen peroxide-induced NADPH oxidase activation and apoptosis in mouse neutrophils.

Yueqin Liu, Wenli Liu, G. Rodgers, 2018, American journal of physiology. Cell physiology.

Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer

Wenli Liu, G. Rodgers, 2016, Cancer and Metastasis Reviews.

RED CELLS, IRON, AND ERYTHROPOIESIS MASL1 induces erythroid differentiation in human erythropoietin-dependent CD34 1 cells through the Raf/MEK/ERK pathway

J. Tisdale, Jianqiong Zhu, G. Rodgers, 2013 .

Kruppel-like factor 1–GATA1 fusion protein improves the sickle cell disease phenotype in mice both in vitro and in vivo

M. Pirooznia, P. Dagur, K. Chin, 2022, Blood.

Basic science: Bedrock of progress.

Elizabeth L. Wilder, Franziska B Greider, N. Volkow, 2016, Science.